Brandi M L, Gennari L, Cerinic M M, Becherini L, Falchetti A, Masi L, Gennari C, Reginster J Y
Department of Medicine, University of Florence, Viale Morgagni 85, 50135 Florence, Italy.
Arthritis Res. 2001;3(5):270-80. doi: 10.1186/ar316. Epub 2001 Jul 4.
Osteoarthritis and osteoporosis are the two most common age-related chronic disorders of articular joints and skeleton, representing a major public health problem in most developed countries. Apart from being influenced by environmental factors, both disorders have a strong genetic component, and there is now considerable evidence from large population studies that these two disorders are inversely related. Thus, an accurate analysis of the genetic component of one of these two multifactorial diseases may provide data of interest for the other. However, the existence of confounding factors must always be borne in mind in interpreting the genetic analysis. In addition, each patient must be given an accurate clinical evaluation, including family history, history of drug treatments, lifestyle, and environment, in order to reduce the background bias. Here, we review the impact of recent work in molecular genetics suggesting that powerful molecular biology techniques will soon make possible both a rapid accumulation of data on the genetics of both disorders and the development of novel diagnostic, prognostic, and therapeutic approaches.
骨关节炎和骨质疏松症是与年龄相关的两种最常见的关节和骨骼慢性疾病,在大多数发达国家是一个重大的公共卫生问题。除了受环境因素影响外,这两种疾病都有很强的遗传成分,现在大量人群研究有相当多证据表明这两种疾病呈负相关。因此,对这两种多因素疾病之一的遗传成分进行准确分析可能会为另一种疾病提供有价值的数据。然而,在解释遗传分析时必须始终牢记混杂因素的存在。此外,为了减少背景偏差,必须对每位患者进行准确的临床评估,包括家族史、药物治疗史、生活方式和环境。在此,我们综述了分子遗传学近期研究工作的影响,表明强大的分子生物学技术将很快使关于这两种疾病遗传学的数据迅速积累以及新型诊断、预后和治疗方法的开发成为可能。